Cardiac effects of antidepressants

Area of Science:

• Pharmacology
• Cardiology
• Geriatric Medicine

Background:

• Tricyclic (TCAs) and tetracyclic antidepressants (TeCAs) are widely used. Their cardiac effects are generally mild.
• Monoamine oxidase inhibitors (MAOIs) are also prescribed but carry significant risks.
• Understanding antidepressant side effects is crucial for patient safety.

Purpose of the Study:

• To review the cardiac effects of TCAs, TeCAs, and MAOIs.
• To highlight the need for clinical monitoring in specific patient populations.
• To emphasize the potential for serious adverse events with MAOIs.

Main Methods:

• Literature review of antidepressant pharmacology and clinical outcomes.
• Analysis of reported cardiac side effects.
• Focus on adverse event profiles in different patient groups.

Main Results:

• TCAs and TeCAs commonly cause benign cardiac effects.
• Older patients with existing conditions require closer cardiac monitoring when using TCAs/TeCAs.
• Orthostatic hypotension is the most frequent adverse effect of MAOIs in healthy adults.
• Hypertensive crisis, a potentially fatal reaction, is the most serious MAOI risk.

Conclusions:

• TCAs and TeCAs are generally well-tolerated, but caution is advised in the elderly.
• MAOIs necessitate careful patient selection and monitoring due to severe cardiovascular risks.
• Awareness of these drug classes' cardiac profiles is essential for safe prescribing practices.